340
Participants
Start Date
September 20, 2017
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2028
RP1
Genetically modified herpes simplex type 1 virus
nivolumab
anti-PD-1 monoclonal antibody
ACTIVE_NOT_RECRUITING
New York University Clinical Cancer Center, New York
RECRUITING
Weill Cornell Medical College, New York
ACTIVE_NOT_RECRUITING
Charité (Campus Benjamin Franklin), Berlin
ACTIVE_NOT_RECRUITING
Service de Dermatologie et Cancerologie Cutanee Hopital de la Timone, Marseille
RECRUITING
University of Rochester Medical Center, Rochester
ACTIVE_NOT_RECRUITING
CHU Dijon, Dijon
ACTIVE_NOT_RECRUITING
University of Kiel (UKSH), Dep. of Dermatology, Kiel
ACTIVE_NOT_RECRUITING
CHU Besancon - Hopital Jean Minjoz, Besançon
RECRUITING
Duke Cancer Center, Durham
ACTIVE_NOT_RECRUITING
Clínica Universidad de Navarra (Madrid), Madrid
RECRUITING
MUSC Health, Charleston
ACTIVE_NOT_RECRUITING
Hospital Universitario Virgen de la Arrixaca, Murcia
ACTIVE_NOT_RECRUITING
Clinica Universitaria de Navarra, Pamplona
ACTIVE_NOT_RECRUITING
Institut Bergonié, Bordeaux
ACTIVE_NOT_RECRUITING
Sylvester Comprehensive Cancer Center- University of Miami, Miami
ACTIVE_NOT_RECRUITING
Uniklinik Marburg, Marburg
ACTIVE_NOT_RECRUITING
University of Birmingham Alabama, Birmingham
RECRUITING
West Cancer Center, Germantown
RECRUITING
James Graham Brown Cancer Center- University of Louisville, Louisville
ACTIVE_NOT_RECRUITING
Hospital Universitario Virgen del Rocio, Seville
ACTIVE_NOT_RECRUITING
University Hospital Essen, Klinik für Dermatologie, Essen
RECRUITING
University of Cincinnati Medical Center, Cincinnati
ACTIVE_NOT_RECRUITING
Hospital General Universitario de Valencia, Valencia
RECRUITING
University of Iowa-Cancer Center Research, Iowa City
ACTIVE_NOT_RECRUITING
University of Wisconsin-Carbone Cancer Center, Madison
RECRUITING
Mayo Clinic, Rochester
ACTIVE_NOT_RECRUITING
Centre Léon Bérard Lyon, Lyon
RECRUITING
Carti Cancer Center, Little Rock
ACTIVE_NOT_RECRUITING
Hôpital Saint Louis APHP, Paris
RECRUITING
The University of Texas MD Anderson Cancer Center, Houston
RECRUITING
Eccles Outpatient Care Center- Oncology Clinical Trials, Murray
RECRUITING
Intermountain Cancer Center- Saint George Cancer Center, St. George
RECRUITING
Mayo Clinic, Phoenix
RECRUITING
Banner MD Anderson Cancer Center, Gilbert
RECRUITING
University of Southern California, Los Angeles
RECRUITING
UCLA, Los Angeles
ACTIVE_NOT_RECRUITING
UC San Diego, La Jolla
RECRUITING
University of California, Irvine, Orange
RECRUITING
University of California- San Francisco, San Francisco
ACTIVE_NOT_RECRUITING
Institut Gustave Roussy, Villejuif
ACTIVE_NOT_RECRUITING
Providence Portland Medical Center, Portland
RECRUITING
Seattle Cancer Care Alliance- University of Washington, Seattle
RECRUITING
Atlantic Health System, Morristown
ACTIVE_NOT_RECRUITING
CHU de Nice Hôpital l'Archet, Nice
ACTIVE_NOT_RECRUITING
Hospital Universitari Vall d'Hebron, Barcelona
ACTIVE_NOT_RECRUITING
Hospital Clinic Barcelona, Barcelona
ACTIVE_NOT_RECRUITING
Institut Catala D'Oncologia - Hospital Duran I, Barcelona
ACTIVE_NOT_RECRUITING
University of Leeds- Teaching Hospital, Leeds
ACTIVE_NOT_RECRUITING
Oxford University Hospitals NHS Trust, Oxford
ACTIVE_NOT_RECRUITING
Royal Marsden Hospital, London
ACTIVE_NOT_RECRUITING
Beatson West of Scotland Cancer Center, Glasgow
ACTIVE_NOT_RECRUITING
The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington
ACTIVE_NOT_RECRUITING
Southampton General Hospital, Southampton
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Replimune Inc.
INDUSTRY